StackTerminal.Health

Supplement Library

Filter by goals, evidence strength, study type, population, & form.

Filters
Goals (main + micro)
Endurance & aerobic
Strength / power
Recovery / soreness
Sleep / calm
Focus / cognitive
Daily baseline
Longevity / metabolic / cardiovascular
Gut / digestion
Women’s health
Constraints
Evidence strength
Study type
Population studied
Form
75 ingredients

5-Amino-1MQ

Low0

Small-molecule NNMT inhibitor discussed in preclinical metabolic/obesity contexts; human evidence is not established in the open literature.

Diet-induced obesity / metabolic endpoints (preclinical)
Typical dose:

Algal Omega-3 EPA/DHA

Moderate1

Plant-derived long-chain omega-3 fatty acids (DHA/EPA) from microalgae; bioequivalent to fish-derived sources.

DHA bioavailability from algal oil versus fish/salmon
Typical dose:

Alpha-Lipoic Acid (ALA)

High0

Alpha-lipoic acid is a universal antioxidant active in both aqueous and lipid compartments that regenerates other antioxidants; it has strong evidence for reducing neuropathic symptoms in diabetic polyneuropathy and improving insulin sensitivity.

Neuropathic symptoms and deficits (intravenous ALA trials)
Typical dose: 600 mg

Apigenin

Very low2

Flavonoid found in chamomile; binds GABA-A receptors with mild anxiolytic/sedative properties. Direct human trials on isolated apigenin are lacking; evidence primarily from chamomile extract RCTs.

Sleep quality (dietary apigenin, cohort data)
Typical dose:

Ashwagandha

Moderate1

Adaptogenic herb with evidence for stress, cortisol reduction, and modest sleep improvement; popular in recovery and wellness contexts.

Sleep quality / sleep onset latency
Typical dose: 600 mg

BPC-157

Low3

Pentadecapeptide with extensive animal/in vitro literature (injury and GI models). Robust human efficacy evidence is lacking.

Musculoskeletal healing (preclinical)
Typical dose:

BPC-157 Arginate (Oral)

Very low0

Oral-marketed BPC-157 variant; clinical outcome evidence for this specific oral formulation is not established.

GI mucosal protection (general BPC-157 literature)
Typical dose:

Beetroot Juice / Dietary Nitrate

Moderate1

Dietary nitrate is converted to nitric oxide, reducing O2 cost of exercise; strongest evidence for sub-elite endurance athletes.

Ergogenic effects of nitrate across sport types and populations
Typical dose: 400 mg

Berberine

Moderate3

Alkaloid from Berberis plants with evidence for glycemic control and lipid improvement.

Dyslipidemia — LDL, triglycerides, total cholesterol
Typical dose:

Beta-Alanine

Moderate5

Raises muscle carnosine, buffering acid during high-intensity exercise lasting 1–4 minutes; causes transient paresthesia (tingling) at higher doses.

Exercise capacity and performance (broader meta-analysis)
Typical dose: 4800 mg

Biotin (Vitamin B7)

Moderate1

Commonly marketed for hair/skin/nails; evidence for benefit in non-deficient individuals is limited. Can interfere with lab tests at higher doses.

Immunoassay interference (thyroid and other tests)
Typical dose: 10 mg

Black Cohosh

Moderate0

Menopause symptom support is mixed; some reviews suggest potential benefit for overall symptoms, but results are inconsistent and product variability is high.

Menopausal symptoms including hot flashes and somatic symptoms
Typical dose: 40 mg

Boron

Low0

Boron is a trace element that modulates sex hormone binding globulin, increases free testosterone and estradiol, enhances vitamin D activity, and supports calcium and magnesium retention in bone; evidence suggests benefits for hormonal balance and bone mineral metabolism.

Free testosterone, estradiol, and inflammatory cytokines in healthy men
Typical dose: 10 mg

Caffeine

High3

Acute performance and alertness benefits; individual sensitivity varies; timing matters for sleep.

Cognitive performance (attention, reaction time)
Typical dose: 200 mg

Cagrilintide

High2

Long-acting amylin analog investigated for obesity/weight management (incl. combinations such as CagriSema). Not a supplement.

Body weight reduction (phase 3 — REDEFINE 1, overweight/obesity without diabetes)
Typical dose: 2 mg

Coenzyme Q10

Low3

Endogenous antioxidant and mitochondrial cofactor with evidence in heart failure and statin-induced myopathy.

Statin-associated muscle symptoms (myalgia, weakness, cramps)
Typical dose:

Coenzyme Q10

Moderate1

Mitochondrial cofactor involved in energy production; used for cardiometabolic and general vitality support.

Mitochondrial / cardiometabolic support
Typical dose: 200 mg

Cordyceps (Ophiocordyceps sinensis / militaris)

Low0

Cordyceps is a medicinal fungus used in traditional Chinese medicine; human RCTs show it may improve aerobic capacity and exercise tolerance, with the militaris strain consistently showing acute and chronic benefits for VO2max and time to exhaustion.

Metabolic threshold and ventilatory threshold during exercise
Typical dose: 1000 mg

Creatine Monohydrate

High6

Supports high-intensity performance and lean mass; among the best-studied sports supplements.

Strength / power performance
Typical dose: 5000 mg

Curcumin Extract

Moderate1

Polyphenol with anti-inflammatory properties that may reduce exercise-induced soreness.

Muscle soreness
Typical dose: 1000 mg

Curcumin Extract

Moderate2

Standardized high-bioavailability curcumin extract with anti-inflammatory and recovery applications.

Delayed-onset muscle soreness (DOMS) reduction after exercise
Typical dose:

EGCG / Green Tea Extract

Moderate0

Epigallocatechin gallate (EGCG) is the principal bioactive catechin in green tea, with thermogenic, antioxidant, and lipid-lowering properties; meta-analyses demonstrate modest but consistent reductions in body weight and cardiovascular risk factors including LDL cholesterol and blood pressure.

Cardiovascular risk factors (lipids, blood pressure, glycemia)
Typical dose: 500 mg

Fenugreek

Low0

Used as a galactagogue; network meta-analysis suggests increased milk volume vs placebo in small RCTs, but evidence base is limited.

Breast milk volume
Typical dose: 5000 mg

Fiber

High0

Dietary fiber supplement supporting gut motility, microbiome diversity, and cardiovascular risk reduction.

LDL cholesterol reduction
Typical dose: 10200 mg

Folic Acid (Folate, B9)

High0

Periconception folic acid lowers neural tube defect risk; standard public-health recommendation is 400 mcg/day for women who could become pregnant.

Neural tube defect prevention
Typical dose:

GHK-Cu

Moderate1

Copper tripeptide used mostly in topical/cosmetic contexts; evidence varies by formulation and endpoint.

Skin appearance / remodeling (summary of clinical + mechanistic evidence)
Typical dose:

GLOW (BPC-157 + TB500/TB4 + GHK-Cu)

Very low0

Blend product. Do not assume combination efficacy/safety from component evidence; direct blend trials are not established.

Combination evidence
Typical dose:

Glutamine

Low0

Glutamine is the most abundant amino acid in the body and the primary fuel for enterocytes and immune cells; evidence supports its role in preserving gut barrier integrity under stress and dramatically reducing symptoms in post-infectious irritable bowel syndrome.

Intestinal permeability in adults
Typical dose: 10000 mg

Glycine

Moderate6

Inhibitory neurotransmitter and structural amino acid; 3 g before bed shows evidence for improving sleep quality and reducing daytime fatigue.

Collagen synthesis / connective tissue support
Typical dose: 15000 mg

HMB (Beta-Hydroxy Beta-Methylbutyrate)

Moderate0

HMB is a metabolite of the branched-chain amino acid leucine that inhibits muscle protein breakdown via the ubiquitin-proteasome pathway; evidence supports modest preservation of lean mass and strength, particularly in older adults and catabolic states.

Skeletal muscle mass and physical function in adults over 50
Typical dose: 3000 mg

Iodine

Low0

Iodine is an essential trace element required for thyroid hormone (T3 and T4) synthesis; severe deficiency causes cretinism and goiter, and adequate intake during pregnancy and early childhood is critical for normal neurodevelopment.

Child development outcomes (cretinism prevention, motor/cognitive) in relation to prenatal iodine
Typical dose:

Iron (Ferrous Bisglycinate)

Moderate0

Ferrous bisglycinate is an amino acid chelate form of iron with superior bioavailability and gastrointestinal tolerability compared to traditional iron salts; it is the first-line choice for iron deficiency anemia supplementation, particularly in pregnancy.

Hemoglobin and ferritin concentrations in iron deficiency
Typical dose: 25 mg

KLOW (BPC-157 + TB500/TB4 + KPV + GHK-Cu)

Very low0

Blend product. Direct clinical evidence for the combination is not established; component evidence does not prove blend outcomes.

Combination evidence
Typical dose:

KPV

Low1

Tripeptide (α-MSH fragment) studied mainly in gut inflammation models; evidence is largely preclinical.

Targeted KPV delivery for ulcerative colitis (preclinical)
Typical dose:

L-Carnitine / Acetyl-L-Carnitine (ALCAR)

Moderate0

L-Carnitine is a fatty acid transporter essential for mitochondrial energy production; its acetylated form ALCAR additionally crosses the blood-brain barrier, acting as an acetylcholine precursor with evidence supporting cognitive function in aging and cardiovascular-metabolic risk reduction.

Cognitive function in mild cognitive impairment and Alzheimer's disease
Typical dose: 2000 mg

L-Citrulline Malate

Moderate3

Precursor to arginine and nitric oxide; used to support blood flow, reduce fatigue, and improve exercise performance.

Systolic blood pressure reduction
Typical dose: 6000 mg

L-Theanine

Low5

Often paired with caffeine for 'calm focus'; evidence suggests reduced jitteriness and improved attention in some contexts.

Cognitive function (standalone L-theanine)
Typical dose: 200 mg

L-Tyrosine

Moderate1

Catecholamine precursor (dopamine, norepinephrine) that may preserve cognitive performance under stress, sleep deprivation, or cold exposure.

Working memory under cold exposure
Typical dose: 2000 mg

Lutein + Zeaxanthin

Moderate0

Supported by AREDS2 context for AMD progression risk reduction when used as part of a specific formula in at-risk populations.

AMD progression to advanced AMD — primary RCT results
Typical dose: 10 mg

MOTS-C

Very low1

Mitochondria-derived peptide with preclinical metabolic/exercise-related findings; limited established human efficacy evidence.

Exercise/metabolic signaling (summary)
Typical dose:

MSM (Methylsulfonylmethane)

Low1

Studied for joint pain/function outcomes; evidence includes placebo-controlled trials with modest improvements in knee OA symptom scores.

Knee joint quality of life / mild knee pain
Typical dose: 2000 mg

Magnesium (Glycinate)

Moderate9

Helpful when dietary magnesium is low; glycinate form is often well-tolerated. Evidence for sleep is mixed but plausible.

Sleep quality in adults with poor sleep (magnesium bisglycinate RCT)
Typical dose: 250 mg

Magnesium Citrate

Moderate2

Highly bioavailable form of magnesium supporting cardiovascular, neuromuscular, and metabolic health.

Bioavailability of magnesium citrate vs oxide and amino-acid chelate
Typical dose: 300 mg

Magnesium L-Threonate

Low0

Magnesium L-threonate is a novel magnesium compound engineered to cross the blood-brain barrier, elevating cerebrospinal fluid magnesium and synaptic density; human RCTs demonstrate improvements in cognitive performance, memory, and sleep quality in adults.

Sleep quality and daytime functioning in adults with sleep problems
Typical dose: 1500 mg

Melatonin

Moderate1

Pineal hormone that regulates circadian rhythms; reduces sleep latency and helps with jet lag and shift work at low doses.

Primary sleep disorders (sleep latency, total sleep time, sleep quality)
Typical dose: 3 mg

Myo-Inositol

Very low0

Naturally occurring sugar alcohol with roles in insulin signalling, PCOS management, and neurological function.

Depression and anxiety symptoms
Typical dose:

NAC (N-Acetyl Cysteine)

Moderate0

N-acetyl cysteine is the rate-limiting precursor for intracellular glutathione synthesis, functioning as an antioxidant, mucolytic agent, and liver protectant; clinical evidence supports its use for hepatoprotection in early acute liver failure and reduction of oxidative stress and inflammatory biomarkers.

Inflammatory and oxidative stress biomarkers
Typical dose: 1200 mg

NAD+

Moderate0

Nicotinamide adenine dinucleotide precursor supplementation to support cellular energy metabolism and longevity pathways.

Blood NAD+ elevation and physical performance (NMN supplementation)
Typical dose: 600 mg

Omega-3 (EPA/DHA)

Low3

Cardiometabolic and inflammation-related outcomes; can support endurance recovery signals; evidence depends on dose and baseline intake.

Delayed-onset muscle soreness (DOMS) after eccentric exercise
Typical dose:

Pineapple Powder

Very low0

Food-based flavoring ingredient to improve palatability and adherence in daily mixes.

Adherence / palatability
Typical dose: 750 mg

Potassium Citrate

Low1

Potassium salt providing the essential electrolyte for cardiovascular and neuromuscular function.

Potassium regulation, muscle fatigue, and exercise performance
Typical dose:

Probiotic Multi-Strain

Moderate0

Multi-strain probiotic formulations supporting gut health, immune function, and respiratory infection prevention.

Global symptom relief in irritable bowel syndrome (IBS)
Typical dose:

Red Clover Isoflavones

Very low0

Studied for menopause symptoms; findings are inconsistent and some studies have higher risk of bias.

Menopausal hot flashes
Typical dose: 80 mg

Retatrutide (LY-343794)

Low3

Investigational triple agonist (GIP/GLP-1/glucagon receptors) studied for obesity; not a dietary supplement. Phase 2 data are robust; phase 3 TRIUMPH program is ongoing.

Phase 3 registrational program design (TRIUMPH)
Typical dose:

Rhodiola Rosea

Low1

Adaptogenic herb with evidence for reducing mental and physical fatigue; used by athletes for anti-fatigue and mild cognitive support.

Endurance performance and physiological biomarkers
Typical dose: 400 mg

SS-31 (Elamipretide)

Moderate1

Mitochondria-targeting peptide investigated clinically; the pivotal phase 3 MMPOWER-3 trial did not meet its primary endpoints in the overall PMM population.

Exercise performance (short-term, earlier phase 2 dose-escalation)
Typical dose:

Selank

Low1

Peptide with anxiolytic claims largely from limited/region-specific clinical literature; evidence quality varies.

Anxiolytic effect vs. phenazepam in anxiety disorders
Typical dose:

Selenium

Moderate0

Selenium is an essential trace mineral incorporated into selenoproteins including glutathione peroxidase and thioiodothyronine deiodinases; the thyroid contains the highest selenium concentration per gram of any tissue, and supplementation reduces thyroid antibodies and supports hormone synthesis in deficient individuals.

Thyroid function, selenium biochemistry, and immune parameters
Typical dose:

Semax

Low0

ACTH fragment analog researched in neuroprotection/nootropic contexts; most evidence is mechanistic/preclinical or limited clinical literature.

Overall brain health evidence appraisal
Typical dose:

Sodium Citrate

Low2

Alkalizing electrolyte salt used as a pre-exercise buffer to attenuate exercise-induced acidosis during high-intensity efforts.

Performance during supramaximal cycling (time to exhaustion)
Typical dose:

Soy Isoflavones

Low0

May reduce menopausal hot flash frequency/severity with small average effect; evidence is mixed and response varies.

Hot flash frequency/severity
Typical dose: 50 mg

TB500 (Fragment)

Very low0

Thymosin fragment sold in research-chemical markets; high-quality human evidence for this fragment form is not established.

Tissue repair plausibility
Typical dose:

TB500 (TB4 / Thymosin Beta-4)

Low2

Thymosin beta-4 is studied in wound-healing contexts (preclinical + some clinical programs). 'TB500' in commerce is often loosely used; do not assume equivalence across products.

Wound healing
Typical dose:

TUDCA (Tauroursodeoxycholic Acid)

Low0

TUDCA is a taurine-conjugated bile acid and chemical chaperone that inhibits ER stress, supports mitochondrial integrity, and exerts hepatoprotective effects; human RCTs demonstrate liver enzyme normalization in cirrhosis and improvements in hepatic insulin sensitivity.

Liver enzymes and biochemical markers in liver cirrhosis
Typical dose: 750 mg

Taurine

Low3

Conditionally essential amino acid with roles in muscle function, antioxidant defense, and calcium handling; common in energy drinks.

Aerobic and strength exercise (dose-response; DNA damage, lactate)
Typical dose: 2000 mg

Theacrine

Low1

Purine alkaloid structurally related to caffeine; found in Camellia kucha tea; marketed for energy and focus with less tolerance development than caffeine.

Cognitive performance and reaction time (combined with caffeine)
Typical dose: 50 mg

Thymosin Beta-4 (TB4) / TB-500 (fragment)

Low0

TB4 has animal wound-healing data and has been evaluated in human wound indications (e.g., venous stasis ulcers). TB-500 is a synthetic fragment; direct clinical evidence for TB-500 itself is limited.

Wound healing (clinical development)
Typical dose:

Vitamin A (Retinol equivalents)

Moderate0

Essential fat-soluble vitamin; pregnancy safety matters (avoid excess preformed vitamin A).

Teratogenicity of excess preformed vitamin A in pregnancy
Typical dose:

Vitamin B-Complex

High0

Bundle of B vitamins; evidence depends on formulation and baseline deficiency. Some RCTs report improved fatigue/exercise outcomes with specific products.

Homocysteine lowering and cardiovascular outcomes
Typical dose:

Vitamin C

Moderate1

General micronutrient; supplementation is context-dependent. Evidence and dosing vary by outcome; high doses can cause GI issues.

Common cold duration and severity
Typical dose: 1000 mg

Vitamin D3

Moderate7

Fat-soluble vitamin with broad roles in immune function, bone health, and musculoskeletal performance.

Fracture prevention in elderly adults
Typical dose:

Vitamin K2 (MK-7)

Moderate0

Menaquinone-7 (MK-7) is the long-chain form of vitamin K2 that activates matrix Gla-protein and osteocalcin, directing calcium to bone rather than arterial walls; evidence from RCTs demonstrates preservation of bone mineral density and reduction of vertebral height loss in postmenopausal women.

Fracture incidence and bone density in postmenopausal osteoporosis
Typical dose:

Vitex agnus-castus

Moderate1

Herbal used for PMS symptom relief; evidence includes RCTs and systematic reviews, though products/extracts vary widely.

PMS symptom remission — meta-analysis of double-blind RCTs
Typical dose: 20 mg

Women's Multivitamin (generic)

High1

Broad coverage product; evidence is nutrient- and deficiency-dependent. Use as a practical baseline when diet is inconsistent; avoid doubling fat-soluble vitamins.

Cancer, cardiovascular disease, and total mortality in postmenopausal women
Typical dose: 1000 mg

Zinc

Moderate1

Essential micronutrient; relevant to immune function and reproductive physiology. Excess zinc can cause copper issues.

Recommended intakes / safety / interactions
Typical dose: 15 mg
Filters expanding over time
Upcoming filters include safety/interaction risk (medications, supplement interactions, WADA), dosing frequency, timing windows, tolerance (GI/taste), cost tiers, and synergy/stacking signals. This is an educational tool — not medical advice.